Integrated multi-omics analysis revealed the molecular networks and potential targets of cellular senescence in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index; none of the 18 sources its claims cite is checked for support yet.
Abstract
Cellular senescence (CS) is a hallmark of Alzheimer’s disease (AD). However, the mechanisms through which CS contributes to AD pathogenesis remain poorly understood. We found that CS level in AD was higher compared with the healthy control group. Transcriptome-based differential expression analysis identified 113 CS-related genes in blood and 410 in brain tissue as potential candidate genes involved in AD. To further explore the causal role of these genes, an integrative mendelian randomization analysis was conducted, combining AD genome-wide association study summary statistics with expression quantitative trait loci (eQTL) and DNA methylation quantitative trait loci (mQTL) data from blood samples, which identified five putative AD-causal genes (CENPW, EXOSC9, HSPB11, SLC44A2, and SLFN12) and 18 corresponding DNA methylation probes. Additionally, integrative analysis between eQTLs and mQTLs from blood uncovered two genes and 12 corresponding regulatory elements involved in AD. Furthermore, two genes (CDKN2B and ITGAV) were prioritized as putative causal genes in brain tissue and were validated through in vitro experiments. The multi-omics integration study revealed the potential role and underlying biological mechanisms of CS driven by genetic predisposition in AD. This study contributed to fundamental understanding of CS in AD pathogenesis and facilitated the identification of potential therapeutic targets for AD prevention and treatment.
Overview
CoChat Summary
TL;DR
This multi-omics Mendelian randomization study found higher cellular senescence levels in Alzheimer’s disease and prioritized several CS-related genes as putative causal AD targets in blood and brain. Blood analyses identified CENPW, EXOSC9, HSPB11, SLC44A2, and SLFN12, while brain analyses identified CDKN2B and ITGAV, with CDKN2B/ITGAV validated in Aβ-treated PC12 cells.
Key findings
- CS level was significantly higher in AD than in healthy controls. Blood transcriptome analysis (139 AD patients vs 134 age- and sex-matched healthy participants) identified 113 CS-related differentially expressed genes (65 upregulated, 48 downregulated); brain transcriptome analysis (310 AD patients vs 157 healthy controls) identified 410 CS-related genes with the same regulatory direction.
- Blood three-step MR identified five putative AD-causal genes: CENPW (OR 0.56; 95% CI 0.41–0.75), EXOSC9 (OR 0.89; 95% CI 0.84–0.95), HSPB11 (OR 0.71; 95% CI 0.55–0.91), SLC44A2 (OR 1.09; 95% CI 1.04–1.13), and SLFN12 (OR 1.13; 95% CI 1.04–1.24). After FDR adjustment, 18 DNA methylation probes of seven genes were selected; integration of eQTL and mQTL data from blood uncovered two genes and 12 corresponding regulatory elements, highlighting EXOSC9 and SLFN12.
- Brain MR identified CDKN2B (OR 1.28; 95% CI 1.10–1.48) and ITGAV (OR 1.09; 95% CI 1.04–1.14) as putative causal genes, plus 15 DNA methylation probes of six genes; no genes or methylation probes intersected between brain eQTL and mQTL results. qPCR and Western blot in Aβ1-42-treated PC12 cells showed significantly higher ITGAV and CDKN2B expression in AD group versus controls.
- Colocalization passed PPH4 > 0.5 for CENPW (PPH4 = 0.554) and SLFN12 (PPH4 = 0.876) in blood, and for CDKN2B (PPH4 = 0.607) in brain.
Methods
- Multi-omics post-GWAS design: CS-related genes were obtained from CellAge (1259 genes; 525 positive, 734 negative), CS score calculated by GSVA as GSVA-up minus GSVA-down. AD differentially expressed genes came from GEO blood GSE63061 (139 AD/134 healthy controls) and brain GSE33000 (310 AD/157 healthy controls). AD GWAS data came from FinnGen R9 (9301 cases, 367,976 controls); cis-eQTL and cis-mQTL data came from blood and brain cohorts.
- Three-step MR analysis tested cis-eQTL → AD, cis-mQTL → AD, and cis-mQTL → cis-eQTL. Instrumental variables were SNPs with P < 5e-6, clumped at r² < 0.1; Wald ratio was used for single-SNP estimates and inverse-variance weighted for multiple SNPs; Cochran’s Q assessed heterogeneity; FDR correction was applied. Colocalization used PPH4 > 0.5, and GO enrichment was performed.
- In vitro validation used PC12 cells treated with Aβ1-42 at 7 μM for 12 h, followed by qPCR and Western blot for ITGAV and CDKN2B.
Limitations
- The paper states: analyses focused only on European populations; mQTL data were limited and some DNA methylation probes lacked corresponding mQTLs; the number of instrumental variables was limited; sex-stratified GWAS data were unavailable; PC12 cells may have species-specific differences from human neurons; and pQTL datasets were not comprehensively developed, so findings were not repeated at the protein level.
- Evident from the text: colocalization supported only CENPW and SLFN12 in blood and CDKN2B in brain, while several prioritized genes/probes did not pass PPH4 > 0.5 (e.g., EXOSC9 cg06713675 PPH4 = 0.027), and brain eQTL/mQTL integration yielded no intersecting genes or methylation probes.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 17 Not checked · 66 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The expression levels of the identified target genes, ITGAV and CDKN2B, were elevated in AD group compared to healthy control in the publicly available dataset (Supplementary Fig. 5A and B).”
§ Integrated multi-omics analysis revealed the molecular networks and potential targets of cellular senescence in Alzheimer's disease > Validation of the target genes expression
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, no genes and DNA methylation probes were intersected.”
§ Integrated multi-omics analysis revealed the molecular networks and potential targets of cellular senescence in Alzheimer's disease > Integration analysis of CS-related cis-e/mQTL and outcome from brain
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that CS level in AD was higher compared with the healthy control group.”
- Also stated in: § Delineate cellular senescence level in AD · plain
“As expected, the CS level in AD group was significantly higher than in healthy control (Supplementary Fig. 1).”
§ Integrated multi-omics analysis revealed the molecular networks and potential targets of cellular senescence in Alzheimer's disease > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Delineate cellular senescence level in AD · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In total, 113 candidate genes were identified, comprising 65 genes upregulated and 48 genes downregulated in both AD and CS (Fig. 2A).”
§ Integrated multi-omics analysis revealed the molecular networks and potential targets of cellular senescence in Alzheimer's disease > Differentially expressed CS genes and potential function from blood
plainstates an associationn = 139- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After FDR adjustment, only 15 DNA methylation probes of six genes were selected (Supplementary Fig. 4).”
§ Integrated multi-omics analysis revealed the molecular networks and potential targets of cellular senescence in Alzheimer's disease > Integration analysis of CS-related cis-e/mQTL and outcome from brain
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
46 more claims
Create a free account to see all 83 claims and to verify the 16 references still open.
- It may state two separate claims as one. 22
- The quote only partly states this claim. 1
- Probably not a substantial claim. 14
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Integrated multi-omics analysis revealed the molecular networks and potential targets of cellular senescence in Alzheimer's disease > Putative CS-causal genes mediated by DNA methylation regulation on gene expression from blood
“higher gene expression of EXOSC9 (EXOSC9 → AD: β = -0.01)”
§ Integrated multi-omics analysis revealed the molecular networks and potential targets of cellular senescence in Alzheimer's disease > Integration analysis of CS-related cis-e/mQTL and outcome from blood
“EXOSC9 (OR: 0.89; 95% CI: 0.84-0.95)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Integrated multi-omics analysis revealed the molecular networks and potential targets of cellular senescence in Alzheimer's disease > Validation of the target genes expression
“we conducted qPCR analysis on independent samples of AD neurons and controls.”
§ Integrated multi-omics analysis revealed the molecular networks and potential targets of cellular senescence in Alzheimer's disease > Statistical analysis
“(E) The qRT-PCR result of CDKN2B mRNA level between control and Aβ1-42 group in PC12 cell.(F) The qRT-PCR result of ITGAV mRNA level between control and Aβ1-42 group in PC12 cell.”
Citations
Cites
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Buniello, A., MacArthur, J. A. L., Cerezo, M., Harris, L. W., Hayhurst, J., Malangone, C., McMahon, A., Morales, J., Mountjoy, E., Sollis, E., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1120 · Cited by 4,000
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Võsa, U., Claringbould, A., Westra, H.-J., Bonder, M. J., Deelen, P., Zeng, B., Kirsten, H., Saha, A., Kreuzhuber, R., Yazar, S., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00913-z · Cited by 2,607
Mendelian Randomization as an Approach to Assess Causality Using Observational Data
Sekula, P., Del Greco M, F., Pattaro, C., & Köttgen, A. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016010098 · Cited by 2,351
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Bussian, T. J., Aziz, A., Meyer, C. F., Swenson, B. L., van Deursen, J. M., & Baker, D. J. (2018) · Nature · doi:10.1038/s41586-018-0543-y · Cited by 1,289
Zhang, P., Kishimoto, Y., Grammatikakis, I., Gottimukkala, K., Cutler, R. G., Zhang, S., Abdelmohsen, K., Bohr, V. A., Misra Sen, J., Gorospe, M., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0372-9 · Cited by 977
Dementia in China: epidemiology, clinical management, and research advances
Jia, L., Quan, M., Fu, Y., Zhao, T., Li, Y., Wei, C., Tang, Y., Qin, Q., Wang, F., Qiao, Y., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30290-x · Cited by 875
Cited by
Dualistic Dynamics in Neuropsychiatry: From Monoaminergic Modulators to Multiscale Biomarker Maps
Tanaka, M., & Battaglia, S. (2025) · Biomedicines · doi:10.3390/biomedicines13061456 · Cited by 11
Xu, Y., Zhang, X., Zhang, Y., Ma, H., Zhou, Z., Qin, H., Liu, H., & Han, X. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106929 · Cited by 7
Self-citationGao, J., Bi, X., Jiang, W., & Wang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-12290-2 · Cited by 6
Wang, G., Duan, J., Sun, L., Pan, S., Liu, Q., Fu, K., Zhang, D., Yuan, X., Fan, B., Hu, B., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147874 · Cited by 5
Zhang, H., Chen, W., Yuan, S., Cai, B., Ding, S., Bao, H., Sun, J., Lu, W., & Zhu, H. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1597511 · Cited by 1
Metadata
- Authors
- Xu, Y., Liu, S., Zhou, Z., Qin, H., Zhang, Y., Zhang, G., Ma, H., Han, X., Liu, H., & Liu, Z.
- Affiliations
- First Affiliated Hospital of Zhengzhou University (CN)
- Zhengzhou University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Corresponding author
- Han, Xinwei
- Liu, Huimin
- Liu, Zaoqu
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2024-12-18
- Volume
- 34
- Issue
- 5
- Pages
- 381-391
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W4405558741
- Cited by
- 6
- References
- 47
- Citations by year
- 2026: 1 · 2025: 5
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Science and Technology Department of Henan (221100310100)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- cellular senescence, Alzheimer's disease, senescence-associated genes, causal genes, SLC44A2, SLFN12, CDKN2B, ITGAV, DNA methylation, expression quantitative trait loci, blood transcriptome, brain transcriptome, therapeutic target
- MeSH terms
- Multiomics, Alzheimer Disease, Brain, Humans, Male, Cellular Senescence, DNA Methylation, Genetic Predisposition to Disease, Gene Expression Profiling, Quantitative Trait Loci, Gene Regulatory Networks, Genome-Wide Association Study, Mendelian Randomization Analysis, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Integrated multi-omics analysis revealed the molecular networks and potential targets of cellular senescence in Alzheimer’s disease. https://app.cochat.ai/papers/10.1093/hmg/ddae189
- The paper
- Xu, Y., Liu, S., Zhou, Z., Qin, H., Zhang, Y., Zhang, G., Ma, H., Han, X., Liu, H., & Liu, Z. (2025). Integrated multi-omics analysis revealed the molecular networks and potential targets of cellular senescence in Alzheimer’s disease. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae189
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.